Advisory Panel Endorse J&J COVID-19 Vaccine For FDA Authorization

A pharmacist prepares to give a COVID-19 vaccine in a file photo. Johnson & Johnson via AP

A panel of advisers to the U.S. Food and Drug Administration on Friday voted in favor of authorizing Johnson & Johnson’s one-dose COVID-19 vaccine for emergency use, bringing it an important step closer to a U.S. rollout.

The FDA is likely to authorize the vaccine for emergency use within a day or so, making it the third available in the United States, and the only one that requires a single shot.